Universidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  2. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

2023

  1. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 1

2022

  1. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors

    Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709

  2. Headache education and management in Cameroon: a healthcare provider study

    Acta Neurologica Belgica, Vol. 122, Núm. 1, pp. 75-81

2021

  1. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

    Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092

  2. Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine

    Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091

  3. Identifying areas for improvement in epilepsy management in developing countries: An experience of neurocooperation in Cameroon

    Neurologia, Vol. 36, Núm. 1, pp. 29-33

2019

  1. Neurología y cooperación: ¿Utopía o realidad? Experiencia de un proyecto pionero de neurocooperación en África

    Kranion, Vol. 14, Núm. 2, pp. 67-72